US 11827600
Crystalline forms of trofinetide
granted A61KA61K38/00A61P
Quick answer
US patent 11827600 (Crystalline forms of trofinetide) held by ACADIA Pharmaceuticals Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00